Meagan E. Anderson

789 total citations
8 papers, 634 citations indexed

About

Meagan E. Anderson is a scholar working on Immunology and Allergy, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Meagan E. Anderson has authored 8 papers receiving a total of 634 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology and Allergy, 5 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Immunology. Recurrent topics in Meagan E. Anderson's work include Cell Adhesion Molecules Research (7 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Immunotherapy and Immune Responses (3 papers). Meagan E. Anderson is often cited by papers focused on Cell Adhesion Molecules Research (7 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Immunotherapy and Immune Responses (3 papers). Meagan E. Anderson collaborates with scholars based in United States. Meagan E. Anderson's co-authors include Teruna J. Siahaan, T. V. Yakovleva, Helena Yusuf‐Makagiansar, Joseph S. Murray, Sumit Majumdar, Cory Berkland, Naoki Kobayashi, Bimo Ario Tejo, Yongbo Hu and Naoki Kobayashi and has published in prestigious journals such as Pharmaceutical Research, Journal of Pharmaceutical Sciences and Medicinal Research Reviews.

In The Last Decade

Meagan E. Anderson

8 papers receiving 621 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meagan E. Anderson United States 8 235 230 228 127 89 8 634
Hiromi Doi Japan 11 275 1.2× 306 1.3× 193 0.8× 129 1.0× 97 1.1× 28 900
Marc Llort Asens Finland 7 241 1.0× 277 1.2× 131 0.6× 34 0.3× 163 1.8× 7 707
Ashfaq A. Parkar United States 9 294 1.3× 78 0.3× 128 0.6× 53 0.4× 78 0.9× 12 612
Graham A. Mackay Australia 15 257 1.1× 442 1.9× 214 0.9× 332 2.6× 53 0.6× 36 840
Ju-Ock Nam South Korea 12 475 2.0× 77 0.3× 139 0.6× 84 0.7× 121 1.4× 15 810
Yanlun Gu China 7 324 1.4× 131 0.6× 131 0.6× 37 0.3× 127 1.4× 12 780
Kim Stecker United States 13 477 2.0× 169 0.7× 83 0.4× 36 0.3× 82 0.9× 22 830
Carla Guenther Finland 9 312 1.3× 292 1.3× 137 0.6× 37 0.3× 189 2.1× 14 841
D M Kazazis United States 10 247 1.1× 89 0.4× 323 1.4× 56 0.4× 71 0.8× 10 833
Mike Maillasson France 17 316 1.3× 271 1.2× 35 0.2× 117 0.9× 215 2.4× 31 761

Countries citing papers authored by Meagan E. Anderson

Since Specialization
Citations

This map shows the geographic impact of Meagan E. Anderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meagan E. Anderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meagan E. Anderson more than expected).

Fields of papers citing papers by Meagan E. Anderson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meagan E. Anderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meagan E. Anderson. The network helps show where Meagan E. Anderson may publish in the future.

Co-authorship network of co-authors of Meagan E. Anderson

This figure shows the co-authorship network connecting the top 25 collaborators of Meagan E. Anderson. A scholar is included among the top collaborators of Meagan E. Anderson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meagan E. Anderson. Meagan E. Anderson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Majumdar, Sumit, et al.. (2012). Methotrexate (MTX)–cIBR Conjugate for Targeting MTX to Leukocytes: Conjugate Stability and In Vivo Efficacy in Suppressing Rheumatoid Arthritis. Journal of Pharmaceutical Sciences. 101(9). 3275–3291. 12 indexed citations
2.
Anderson, Meagan E., Bimo Ario Tejo, T. V. Yakovleva, & Teruna J. Siahaan. (2006). Characterization of Binding Properties of ICAM‐1 Peptides to LFA‐1: Inhibitors of T‐cell Adhesion. Chemical Biology & Drug Design. 68(1). 20–28. 19 indexed citations
3.
Anderson, Meagan E., et al.. (2006). Cell Adhesion Molecules for Targeted Drug Delivery. Journal of Pharmaceutical Sciences. 95(9). 1856–1872. 101 indexed citations
4.
Anderson, Meagan E., et al.. (2006). Cell Adhesion Molecules for Targeted Drug Delivery. Journal of Pharmaceutical Sciences. 96(1). 234–234. 14 indexed citations
5.
Anderson, Meagan E., T. V. Yakovleva, Yongbo Hu, & Teruna J. Siahaan. (2004). Inhibition of ICAM-1/LFA-1-mediated heterotypic T-cell adhesion to epithelial cells: design of ICAM-1 cyclic peptides. Bioorganic & Medicinal Chemistry Letters. 14(6). 1399–1402. 21 indexed citations
6.
Anderson, Meagan E. & Teruna J. Siahaan. (2003). Mechanism of Binding and Internalization of ICAM-1-Derived Cyclic Peptides by LFA-1 on the Surface of T Cells: A Potential Method for Targeted Drug Delivery. Pharmaceutical Research. 20(10). 1523–1532. 35 indexed citations
7.
Anderson, Meagan E. & Teruna J. Siahaan. (2003). Targeting ICAM-1/LFA-1 interaction for controlling autoimmune diseases: designing peptide and small molecule inhibitors. Peptides. 24(3). 487–501. 113 indexed citations
8.
Yusuf‐Makagiansar, Helena, Meagan E. Anderson, T. V. Yakovleva, Joseph S. Murray, & Teruna J. Siahaan. (2002). Inhibition of LFA‐1/ICAM‐1 and VLA‐4/VCAM‐1 as a therapeutic approach to inflammation and autoimmune diseases. Medicinal Research Reviews. 22(2). 146–167. 319 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026